Dr. Amy Clark
Claim this profileUniversity of Pennsylvania
Studies Breast Cancer
Studies Tumors
10 reported clinical trials
29 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 positive
ER positive
2Tumors
ER positive
ER negative
HER2 positive
Affiliated Hospitals
Clinical Trials Amy Clark is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Niraparib + Trastuzumab
for Breast Cancer
The human epidermal growth factor receptor 2 (HER2) regulates cell growth and survival. Approximately 15-20% of all breast cancers are HER2-positive, which are an aggressive and fast-growing subtype of breast cancer. This study will evaluate a new treatment using a potent Poly polymerase (PARP) inhibitor known as Niraparib. Niraparib will be combined with trastuzumab, a HER2-targeted agent, to evaluate the safety and tolerability in patients with metastatic HER2 positive breast cancer. It is anticipated that the combination of drugs will improve survival and have few side effects.
Recruiting1 award Phase 1 & 213 criteria
More about Amy Clark
Clinical Trial Related1 year of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Amy Clark has experience with
- Trastuzumab
- Avelumab
- Tucatinib
- T-DM1
- Placebo
- Niraparib
Breakdown of trials Amy Clark has run
Breast Cancer
Tumors
Hemangiosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amy Clark specialize in?
Amy Clark focuses on Breast Cancer and Tumors. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Amy Clark currently recruiting for clinical trials?
Yes, Amy Clark is currently recruiting for 4 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Amy Clark has studied deeply?
Yes, Amy Clark has studied treatments such as Trastuzumab, Avelumab, Tucatinib.
What is the best way to schedule an appointment with Amy Clark?
Apply for one of the trials that Amy Clark is conducting.
What is the office address of Amy Clark?
The office of Amy Clark is located at: University of Pennsylvania, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the University of Pennsylvania.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.